Global Mirtazapine Market Size, Share and Trends Analysis Report, By Type (15mg Tablet, 30mg Tablet, 45mg Tablet), By Application (Hospital, Drug Store), Forecast (2022-2028)

The global mirtazapine market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Mirtazapine is a type of antidepressant belonging to the serotonin-norepinephrine reuptake inhibitor. It contains both the features of SSRIs and SNRIs, so it can be used as an alternative treatment for people who do not respond well to antidepressants that contain only SSRIs. The increasing prevalence of anxiety among patients is one of the key factor driving the global mirtazapine market.

Mirtazapine should not be used to treat children and adolescents under 18 years of age. Suicide-related behaviors, as well as hatred especially anger, antagonistic behavior, and anger, were more commonly seen in clinical trials among children and adolescents treated with antidepressant medications compared with those treated with placebo. If, based on the need for a clinic, the treatment decision is taken, however, the patient should be monitored carefully to show signs of suicide. Additionally, long-term safety data for children and adolescents regarding growth, maturity, and mental and behavioral development are lacking.

Based on the type segment 30mg tablet of mirtazapine should not be used to treat children and adolescents under 18 years of age. Suicide-related behaviors, as well as hatred especially anger, antagonism, and anger, were more frequently observed in clinical trials among children and adolescents treated with antidepressants compared with those treated with placebo. If, based on clinical need, a treatment decision is taken, however, the patient should be monitored carefully to show signs of suicide. Additionally, long-term safety data for children and adolescents regarding growth, maturity, and mental and behavioral development are lacking. Looking towards the product demand, in January 2020, Aurobindo Pharma USA, Inc. issued a voluntary recall nationwide of certain mirtazapine tablets as bottles labeled 7.5mg may contain 15mg tablets.

Market Coverage

• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
  • By Type
  • By Application
• Regions Covered-
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
• Competitive Landscape– APOTEX, Aurobindo Pharma, Merck & Co., Sun Pharmaceutical, and Zydus Pharmaceutical, among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How has COVID-19 impacted the market?
  • Deviation from the pre-COVID-19 forecast
  • Most affected region and segment
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global MirtazapineMarket Report by Segment

By Type

• 15mg Tablet
• 30mg Tablet
• 45mg Tablet

By Application

• Hospital
• Drug Store

Global MirtazapineMarket Report by Region

North America

• United States
• Canada

Europe

• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe

Asia-Pacific

• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific

Rest of the World

• Latin America
• Middle East & Africa